John Libbey Eurotext

European Journal of Dermatology

MENU

The incidence of non-melanoma skin cancer in the UK and the Republic of Ireland: a systematic review Volume 33, issue 3, May-June 2023

Figures


  • Figure 1

  • Figure 2

  • Figure 3

  • Figure 4

  • Figure 5

  • Figure 6

  • Figure 7

  • Figure 8

  • Figure 9

  • Figure 10

Tables

Authors
1 Reconstructive Surgery & Regenerative Medicine Research Centre (ReconRegen) Swansea University Medical School, Institute of Life Sciences, Swansea, SA2 8PP, UK
2 The Welsh Centre for Burns & Plastic Surgery, Morriston Hospital, Swansea, SA6 6NL, UK
3 Swansea University Medical School, Institute of Life Sciences, Swansea, SA2 8PP, UK
* Reprints: Iain S. Whitaker

Keratinocyte cancers (KC), which encompass both basal cell carcinoma (BCC) and squamous cell carcinoma (cSCC), remain the most prevalent malignant tumour within the Caucasian population.In the UK, there were an estimated 152,000 new cases of non-melanoma skin cancer (NMSC) per year between 2015 and 2017 with a 166% increase since the 1990s [1]. Although these tumours are associated with a low mortality, they have a significant global impact in terms of morbidity and resource implication. Increasing [...]